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Long-term potentiation (LTP) is a long-lasting enhance-
ment of synaptic transmission efficacy and is considered
the base for some forms of learning and memory.
Hyperammonemia is considered the main responsible for
the neurological alterations found in liver disease and
hepatic encephalopathy, including decreased intelectual
and cognitive function. Ammonia affects both excitatory
and inhibitory synaptic transmission in the mammalian
brain by a variety of mechanisms. LTP is impaired in
hyperammonemia and this may contribute to the impair-
ment of cognitive function. However the mechanism by
which hyperammonemia impairs LTP remains unclear.
We have demnostrated that a sequential activation of sol-
uble guanylate cyclase (sGC), cGMP-dependent protein
kinase (PKG) and cGMP-degrading phosphodiesterase
(PDE) is necessary for proper induction of LTP.
Application of the tetanus induces a rapid rise in cGMP,
reaching a maximum 10 seconds after the tetanus. cGMP
decreased below basal levels 5 min after the tetanus
remaining low at least until 60 min. The activity of sGC
increase at 10 seconds after tetanus remaining high at 5
min and returning to basal levels at 60 min. after the teta-
nus. This explains the initial transient increase in cGMP.
The subsequent decrease in cGMP is due to sustained tet-
anus-induced increase in the activity of cGMP-degrading
phosphodiesterase, which remains activated 60 min. after
tetanus. We studied the mechanism by which the tetanus
induces the activation of PDE. Tetanus-induced activation
of PDE and decrease of cGMP were prevented by inhibit-
ing PKG. This indicates that the initial increase in cGMP
activates PKG that phosphorylates (and activates) PDE,
which, in turn, degrades cGMP. Inhibition of any step of
this pathway impairs LTP, indicating that proper induc-
tion of LTP involves activation of this pathway.
We found that hyperammonemia impairs LTP in hippoc-
ampus by altering the modulation of this sGC-PKG-cGMP
degrading PDE pathway. Exposure of hippocampal slices
to 1 mM ammonia completely prevents tetanus-induced
decrease of cGMP by imparing PKG-mediated activation
of cGMP-degrading phosphodiesterase. LTP is also
impaired in hippocampal slices from hyperammonemic
rats without liver failure and from rats with portacaval
anastomosis, an experimental model of hepatic failure.
The impairment is more severe in rats with portacaval
anastomosis. These alterations in LTP may be involved in
the cognitive impairment in patients with hepatic enceph-
alopathy.
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